NCT01955343已完成不适用
Immune Response in Lung Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- progression-free survival
研究概览
简要总结
This study is designed to evaluate the importance of the immune cells localization (distribution) between malignant tumor islets and surrounding stroma and to investigate the associations between these immune cells as well as cytokines and clinicopathological and prognostic factors of non-small cell lung cancer (NSCLC) patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Eastern Cooperative Oncology Group (ECOG) score of 0-1
- •Patients with histologically documented non-small cell lung cancer
- •Control group - patients without non-small cell lung cancer
- •Written (signed) Informed Consent to participate in the study
排除标准
- •Any other malignancies within 5 years
- •Any unstable systemic disease (including active infections, significant cardiovascular disease)
- •Prior chemotherapy or radiotherapy
- •Autoimmune disease
- •Nursing or pregnant women
结局指标
主要结局
progression-free survival
时间窗: one year after enrolment to the study
次要结局
- overall survival(3 years)
研究者
Marius Zemaitis
Assoc. Professor
Lithuanian University of Health Sciences
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
ongitudinal analysis of lung cancer-specific immunity in stage III and IV non-small cell lung cancer patients10038666non-small cell lung cancerNL-OMON37300Antoni van Leeuwenhoek Ziekenhuis50
招募中
不适用
ongitudinal analysis of lung cancer-specific immunity in stage III and IV non-small cell lung cancer patients.NL-OMON25535Stichting Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek ZiekenhuisAmsterdam, The Netherlands50
招募中
3 期
Efficacy and Biomarker Development for Lung Cancer Treated With Immune Checkpoint InhibitorsLung CancerNCT05055908Hunan Province Tumor Hospital12,000
已完成
不适用
Mechanisms of Immunosurveillance for Lung CancerLung CancerNCT01710319Washington University School of Medicine119
已完成
不适用
Study of Anti-telomerase T CD4 Immunity in Metastatic Lung CancerLung CancerNCT02846103Centre Hospitalier Universitaire de Besancon321